34th annual EMSOS congress. Day 3
The importance of the musculoskeletal tumors cannot be overestimated. Huge scientific and financial resources are involved in this section of oncology. Each annual EMSOS congress sums up the accumulated knowledge in the morphology and development of skeletal leasions, offers new methods of diagnosis and treatment. Each year, EMSOS demonstrates innovations that allow to manage malignant tumors, achieve regression and prolong the life of patients. The fundamentality of scientific research and discoveries can be assessed by the reports of leading experts in oncoorthopedics:
- "Research in Rare Tumors - How to Collaborate" Prof Michiel Van de Sande, Professor of Orthopedic Oncology, Leiden University Medical Centre, Leiden, Netherlands
- "Progresses and future directions in musculoskeletal oncology and the role of International Societies" Prof Pietro Ruggieri, University of Padova, Italy
- "Controversies in Chondrosarcoma" by Prof Lee Jeys. Professor of Orthopedic Oncology, Royal Orthopedic Hospital, Birmingham, UK
- CAMPAMACCI LECTURE: “The evolution of pelvic surgery. A journey from hind quarter amputation to custom reconstruction” Prof Paul Stalley, AM, Sydney
- "Mental and Physical Wellbeing in Sarcoma - not just for patients" Dr Ahmed Aber. General Surgery Registrar/South London Rotation. H.Lecturer/Health Economics & Decision Science, University of Sheffield
Stay with medpresso.org for the most important news in world medicine.